In this free webinar, gain insights into the critical considerations for an early-phase oncology study startup. Attendees will learn about the logistics of trial management, including the distribution of materials such as investigational products, lab kits and ancillary supplies. The featured speakers will share insights for operational excellence in the execution of early-phase oncology trials, focusing on the critical paths for delivery. Attendees will learn how a patient-centric approach will ensure coordination and criticality to benefit patients.
TORONTO, Feb. 26, 2025 /PRNewswire-PRWeb/ -- The early-phase oncology clinical trial landscape is constantly evolving, influenced by shifts in regulatory guidance such as Project Optimus and multiregional clinical development programs.
Project Optimus emphasizes dose optimization earlier in the trial process, leading to more complex study designs that require larger sample sizes and a broader global footprint. Initiatives to refine dosing strategies to enhance patient safety and efficacy necessitate more intricate planning and execution of clinical trials.
The focus on dose optimization means that researchers must carefully balance the need for robust data with the practicalities of patient recruitment and retention, often across multiple countries and regulatory environments. Operational execution of these trials involves coordination of numerous factors, especially during study startup and planning of trial logistics.
Managing early-phase oncology clinical trials has become increasingly complex, necessitating a strong command of country- and site-level feasibility, ethics, and informed consent to ensure success. Getting global study teams up and running, then requiring them to successfully navigate cultural differences and be well-versed in local regulatory, data privacy, and ethical requirements, can impact study startup, site selection, and patient recruitment.
The ability to adapt to varying regulatory landscapes and ensure compliance with local laws is crucial for the smooth trial initiation and progression. Additionally, understanding the nuances of data privacy regulations in different regions helps in safeguarding patient information and maintaining trust.
Enrollment and cohort management are particularly challenging in global trials with strategic multiple sites across various regions and time zones. Teams must be proficient in protocol inclusion and exclusion criteria while understanding diversity and study design requirements such as multiple treatment arms, varying dosages, prevalence and prominence of the indication and adaptive design considerations.
Ensuring that all sites are adequately staffed and equipped to handle the specific needs of different cohorts is logistically demanding. This includes coordinating the availability of specialized medical personnel, ensuring the proper functioning of medical equipment and maintaining a steady supply of necessary materials.
Additionally, layering in risk-based monitoring, safety review, vendor management, investigational product logistics and sample management create additional complexities on a global scale. Effective communication and coordination among all stakeholders are essential to address these challenges and ensure a trial's success.
Understanding these numerous factors and mitigating various risks are essential for early-phase oncology trials to ensure patients benefit throughout because they represent the end goal. In this webinar, the expert speakers will share lessons learned, best practices and tangible examples from their experiences in operationalizing global, complex early-phase oncology trials. This event will provide valuable insights into overcoming the common hurdles faced in these trials and offer strategies to enhance efficiency and effectiveness.
Register for this webinar today to gain actionable strategies, lessons learned and best practices to enhance the success of complex early-phase oncology trials.
Join Keya Watkins (moderator), Senior Vice President, Catalyst Oncology, Catalyst Clinical Research; Marcia Milholen, Vice President, Central Site Services, Catalyst Clinical Research; John McAdory, MHA, Vice President, Clinical Operations, CG Oncology; and Dora Ferrari, Vice President, Clinical Operations, Curis, for the live webinar on Wednesday, March 19, 2025, at 11am EDT (4pm CET/EU-Central).
For more information, or to register for this event, visit Best Practices for Operationalizing Global, Early-Phase Oncology Trials.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com
SOURCE Xtalks
Share this article